Cognitive Therapy for Schizophrenia: Treatment and Dissemination

E-ISSN： 1873-4286|10|18|2269-2275

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.18, 2004-07, pp. : 2269-2275

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Feasibility of Dissemination of Cognitive Behavioral Therapy to Texas Community Mental Health Centers

By Lopez Molly

The Journal of Behavioral Health Services & Research, Vol. 38, Iss. 1, 2011-01 ,pp. : 91-104

Springer Publishing Company

Access to resources Recommend Favorite

Adrenergic targets for the treatment of cognitive deficits in schizophrenia

By Arnsten Amy

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 25-31

Springer Publishing Company

Access to resources Recommend Favorite

GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia

Current Neuropharmacology, Vol. 3, Iss. 1, 2005-01 ,pp. : 45-62

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Current Pro-Cognitive Therapeutic Strategies for Improved Pharmacological Treatment in Schizophrenia

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-09 ,pp. : 5045-5045

Bentham Science Publishers

Access to resources Recommend Favorite

Intracellular Signaling and Approaches to the Treatment of Schizophrenia and Associated Cognitive Impairment

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-09 ,pp. : 5093-5103

Bentham Science Publishers

Access to resources Recommend Favorite